Copyright
©The Author(s) 2025.
World J Virol. Jun 25, 2025; 14(2): 106479
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.106479
Published online Jun 25, 2025. doi: 10.5501/wjv.v14.i2.106479
Table 1 Patients’ characteristics, mean ± SD
Variables | Non-responder | Responder | P value |
Gender (male/female) | 30/45 | 40/60 | 0.242 |
Age (years) | 51.55 ± 6.99 | 49.4 ± 7.0 | 0.071 |
Alanine aminotransaminase (U/L) | 70.2 ± 21.0 | 60.0± 15.8 | 0.017 |
Aspartate aminotransaminase (U/L) | 68.9 ± 16.9 | 54.6 ± 14.9 | 0.004 |
ALP (U/L) | 123.9 ± 32.8 | 98.9 ± 20.9 | 0.018 |
Bilirubin (mg/dL) | 1.15 ± 0.28 | 0.96 ± 0.35 | 0.011 |
Albumin (g/dL) | 3.35 ± 0.39 | 3.88 ± 0.51 | 0.0001 |
Creatinine (mg/dL) | 0.87 ± 0.18 | 0.81 ± 0.16 | 0.082 |
α-fetoprotein (ng/mL) | 3.62 ± 1.19 | 3.59 ± 0.88 | 0.769 |
INR | 1.25 ± 0.15 | 1.13 ± 0.06 | 0.069 |
Hemoglobin (g/dL) | 11.88 ± 2.60 | 13.10 ± 1.34 | 0.071 |
Platelets (× 109/L) | 155.9 ± 43.9 | 191.2 ± 35.9 | 0.0001 |
White blood cells (× 109/L) | 4.91 ± 1.67 | 5.49 ± 1.37 | 0.0620 |
Red blood cells (× 1012/L) | 5.33 ± 1.88 | 4.98 ± 1.17 | 0.0840 |
APRI | 1.20 ± 0.31 | 0.78 ± 0.22 | 0.0001 |
FIB-4 | 3.11 ± 1.01 | 1.94 ± 0.56 | 0.0001 |
Table 2 Diagnostic performances of the index compared to each marker alone
Categories | AUC (95%CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) |
PIIINP ≥ 19.5 μg/L | 0.684 (0.59-0.78) | 69.3 | 50 | 51.0 | 68.5 | 58.3 |
HA ≥ 82 μg/L | 0.766 (0.66-0.87) | 70.7 | 69 | 63.1 | 75.8 | 69.71 |
PIIINP × HA > 1840 | 0.809 (0.72-0.90) | 74.7 | 74 | 68.3 | 79.6 | 74.3 |
Table 3 Correlation between the index and each marker alone with factors related to treatment failure
Variable | HA × PIIINP | HA | PIIINP | |||
r | P value | r | P value | r | P value | |
ALT (U/L) | 0.182 | 0.091 | 0.127 | 0.096 | 0.121 | 0.210 |
AST (U/L) | 0.212 | 0.089a | 0.114 | 0.133 | 0.150 | 0.182 |
ALP (U/L) | 0.191 | 0.059 | 0.112 | 0.214 | 0.071 | 0.261 |
Albumin (g/dL) | -0.26 | 0.021a | -0.20 | 0.044a | -0.201 | 0.043a |
Bilirubin (mg/dL) | 0.194 | 0.062 | 0.136 | 0.079 | 0.099 | 0.223 |
Platelets (× 109/L) | -0.19 | 0.058 | -0.13 | 0.083 | -0.123 | 0.158 |
FIB-4 | 0.216 | 0.022a | 0.186 | 0.041a | 0.185 | 0.041a |
APRI | 0.223 | 0.019a | 0.188 | 0.041a | 0.181 | 0.041a |
- Citation: Abdelrazek MA, Elghwab AI, Tabll AA, Elsayed EH, El Behery M. Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals. World J Virol 2025; 14(2): 106479
- URL: https://www.wjgnet.com/2220-3249/full/v14/i2/106479.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i2.106479